Reading Time: 6 minutesOver the last year ALS/MND clinical trials have taken centre stage, with more trials than ever opening for recruitment in the UK, the news of promising results from some trials and the approval of drugs by some regulatory authorities. With the year coming to an end, we thought we would roundup some recent clinical trial updates that were presented at the 33rd International Symposium on ALS/MND.
Category: Research we fund
Reading Time: 5 minutesThe top-line results of the Modifying Immune Response and OutComes in ALS (MIROCALS) clinical trial were announced on 6 December 2022 at the 33rd International Symposium
Reading Time: 2 minutesHello, my name is Judith Bilgorai and I am a first year PhD student, funded by the MND Association, at King’s College London. I work
Reading Time: 6 minutesA newly published paper in Acta Neuropathologica Communications has shed light on the behaviour of healthy motor neurones compared to motor neurones found in MND.
Reading Time: 4 minutesEvery year at the European Network to Cure ALS (ENCALS) meeting, the Young Investigator award is presented to the brightest and best young scientist in
Reading Time: 5 minutesEach year, the 21st of June marks Global MND Awareness Day and MND Charites and Associations across the world acknowledge the impact that MND has
32nd Symposium: Virtual 32nd Symposium: Virtual Clinical Trials MND Research Research we fund Symposium Treatments
Symposium Spotlight: A closer look at IMODALS clinical trial outcomes
Reading Time: 6 minutesAs the research team are starting to get stuck into planning our next International Symposium on ALS/MND we are taking a look back at some
Reading Time: 3 minutesLike many things we take for granted, it’s easy to forget the importance of our saliva. Until we begin to think about it, we are
Reading Time: 5 minutesThis is blog number 11 in our ‘Symposium Blogathon’ – counting down to the 32nd International Symposium on ALS/MND. Numbers in bold green type correspond